BRPI0811533A2 - Método para a produção de um vírus - Google Patents

Método para a produção de um vírus

Info

Publication number: BRPI0811533A2
Authority: BR; Brazil
Prior art keywords: virus; producing
Prior art date: 2007-05-04

Application number

BRPI0811533-8A2A

Other languages

English (en)

Inventor

Manfred Reiter

Leopold Grillberger

Wolfgang Mundt

Original Assignee

Baxter Int

Baxter Healthcare Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-05-04

Filing date

2008-04-30

Publication date

2014-10-14

2008-04-30 Application filed by Baxter Int, Baxter Healthcare Sa filed Critical Baxter Int

2014-10-14 Publication of BRPI0811533A2 publication Critical patent/BRPI0811533A2/pt

Links

241000700605 Viruses Species 0.000 title 1
238000004519 manufacturing process Methods 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/04—Inactivation or attenuation; Producing viral sub-units
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/02—Recovery or purification
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16151—Methods of production or purification of viral material
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16251—Methods of production or purification of viral material
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24151—Methods of production or purification of viral material
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/36011—Togaviridae
- C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
- C12N2770/36151—Methods of production or purification of viral material
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Immunology (AREA)
Virology (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Wood Science & Technology (AREA)
Genetics & Genomics (AREA)
Zoology (AREA)
Microbiology (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Biomedical Technology (AREA)
Mycology (AREA)
Epidemiology (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Pulmonology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

BRPI0811533-8A2A 2007-05-04 2008-04-30 Método para a produção de um vírus BRPI0811533A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US92769307P	2007-05-04	2007-05-04
PCT/EP2008/003532 WO2008135230A1 (en)	2007-05-04	2008-04-30	Two-step temperature profile for the propagation of viruses

Publications (1)

Publication Number	Publication Date
BRPI0811533A2 true BRPI0811533A2 (pt)	2014-10-14

Family

ID=39670405

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0811533-8A2A BRPI0811533A2 (pt)	2007-05-04	2008-04-30	Método para a produção de um vírus

Country Status (19)

Country	Link
US (2)	US20100239606A1 (pt)
EP (1)	EP2155863B1 (pt)
JP (2)	JP5352578B2 (pt)
KR (1)	KR101581228B1 (pt)
CN (2)	CN101688186A (pt)
AR (1)	AR066450A1 (pt)
AU (1)	AU2008248905B2 (pt)
BR (1)	BRPI0811533A2 (pt)
CA (1)	CA2687122C (pt)
CL (1)	CL2008001295A1 (pt)
ES (1)	ES2521496T3 (pt)
HK (1)	HK1216104A1 (pt)
IL (1)	IL201896A (pt)
MX (1)	MX2009011899A (pt)
PE (1)	PE20090214A1 (pt)
RU (1)	RU2476594C2 (pt)
TW (1)	TWI447226B (pt)
WO (1)	WO2008135230A1 (pt)
ZA (1)	ZA200907744B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2914163B1 (fr) *	2007-04-02	2009-06-05	Oreal	Applicateur pour appliquer une composition sur les cils
EP2838910A4 (en)	2012-04-18	2015-12-09	Mayo Foundation	REPLICATION COMPETENT STOMATITIS VESICULARIS VIRUS

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE1526172A1 (de) *	1965-04-22	1969-07-31	Steinmueller Gmbh L & C	Aus mehreren Stufen aufgebauter Regenerativ-Waermeaustauscher
US4301250A (en) *	1979-11-02	1981-11-17	Merck & Co., Inc.	Method of producing hepatitis B surface antigen
US4301249A (en) *	1980-07-23	1981-11-17	Merck & Co., Inc.	High titer production of hepatitis A virus
FR2723740B1 (fr) *	1994-08-16	1996-11-08	Pasteur Merieux Serums Vacc	Procede de preparation d'antigenes du virus grippal, antigenes obtenus et leurs applications
DE19612967A1 (de) *	1996-04-01	1997-10-02	Behringwerke Ag	Verfahren zur Vermehrung von Influenzaviren in Zellkultur, sowie die durch das Verfahren erhältlichen Influenzaviren
RU2181295C1 (ru) *	2000-12-27	2002-04-20	Научно-исследовательский институт вирусологии им. Д.И. Ивановского РАМН (учреждение)	Вирионная цитомегаловирусная вакцина и способ ее получения
US6855535B2 (en) *	2001-12-10	2005-02-15	Baxter Healthcare S.A.	Method of large scale production of Hepatitis A virus
US6951752B2 (en) *	2001-12-10	2005-10-04	Bexter Healthcare S.A.	Method for large scale production of virus antigen
WO2003085138A1 (en) *	2002-03-29	2003-10-16	Merck & Co., Inc.	Methods of virus production
CA2523319A1 (en) *	2003-04-25	2004-11-11	Medimmune Vaccines, Inc.	Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus
JP2007068401A (ja) *	2003-08-07	2007-03-22	Chemo Sero Therapeut Res Inst	西ナイルウイルスワクチン
DK2368975T3 (en) *	2004-12-23	2015-01-05	Medimmune Llc	Non-tumorigenic MDCK cell line for the propagation of viruses

2008
- 2008-04-30 BR BRPI0811533-8A2A patent/BRPI0811533A2/pt not_active IP Right Cessation
- 2008-04-30 MX MX2009011899A patent/MX2009011899A/es active IP Right Grant
- 2008-04-30 US US12/598,720 patent/US20100239606A1/en not_active Abandoned
- 2008-04-30 ES ES08749279.9T patent/ES2521496T3/es active Active
- 2008-04-30 KR KR1020097025227A patent/KR101581228B1/ko active Active
- 2008-04-30 WO PCT/EP2008/003532 patent/WO2008135230A1/en not_active Ceased
- 2008-04-30 US US12/112,261 patent/US8426124B2/en active Active
- 2008-04-30 RU RU2009144970/10A patent/RU2476594C2/ru not_active IP Right Cessation
- 2008-04-30 CA CA2687122A patent/CA2687122C/en active Active
- 2008-04-30 CN CN200880021212A patent/CN101688186A/zh active Pending
- 2008-04-30 JP JP2010504578A patent/JP5352578B2/ja active Active
- 2008-04-30 CN CN201510118812.0A patent/CN104962525A/zh active Pending
- 2008-04-30 EP EP08749279.9A patent/EP2155863B1/en active Active
- 2008-04-30 AU AU2008248905A patent/AU2008248905B2/en active Active
- 2008-05-02 TW TW097116166A patent/TWI447226B/zh not_active IP Right Cessation
- 2008-05-05 PE PE2008000784A patent/PE20090214A1/es not_active Application Discontinuation
- 2008-05-05 CL CL2008001295A patent/CL2008001295A1/es unknown
- 2008-05-05 AR ARP080101903A patent/AR066450A1/es unknown
2009
- 2009-11-03 IL IL201896A patent/IL201896A/en active IP Right Grant
- 2009-11-04 ZA ZA200907744A patent/ZA200907744B/xx unknown
2013
- 2013-07-05 JP JP2013141293A patent/JP5978172B2/ja active Active
2016
- 2016-03-16 HK HK16103061.0A patent/HK1216104A1/zh unknown

Also Published As

Publication number	Publication date
CL2008001295A1 (es)	2009-06-26
JP5978172B2 (ja)	2016-08-24
JP5352578B2 (ja)	2013-11-27
TWI447226B (zh)	2014-08-01
HK1137780A1 (en)	2010-08-06
RU2009144970A (ru)	2011-06-10
AU2008248905B2 (en)	2014-05-29
ZA200907744B (en)	2010-08-25
EP2155863A1 (en)	2010-02-24
US8426124B2 (en)	2013-04-23
CN101688186A (zh)	2010-03-31
US20080286307A1 (en)	2008-11-20
WO2008135230A1 (en)	2008-11-13
IL201896A (en)	2013-08-29
TW200914616A (en)	2009-04-01
KR101581228B1 (ko)	2015-12-30
JP2010525799A (ja)	2010-07-29
EP2155863B1 (en)	2014-08-13
CA2687122C (en)	2017-06-13
KR20100017593A (ko)	2010-02-16
MX2009011899A (es)	2010-03-30
IL201896A0 (en)	2011-08-01
ES2521496T3 (es)	2014-11-12
HK1216104A1 (zh)	2016-10-14
AR066450A1 (es)	2009-08-19
RU2476594C2 (ru)	2013-02-27
US20100239606A1 (en)	2010-09-23
CA2687122A1 (en)	2008-11-13
JP2013198502A (ja)	2013-10-03
PE20090214A1 (es)	2009-03-20
AU2008248905A1 (en)	2008-11-13
CN104962525A (zh)	2015-10-07

Legal Events

Date	Code	Title
2015-10-13	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
2018-02-27	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
2018-06-12	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]
2022-07-12	B350	Update of information on the portal [chapter 15.35 patent gazette]

Publication	Publication Date	Title
BRPI0919250A2 (pt)	2015-12-15	métodos para a purificação de vírus
BRPI0813903A2 (pt)	2014-12-30	Processos para a prepração de pirazóis
BRPI0819568A2 (pt)	2017-07-04	métodos para a preparação de um composto
BRPI0906906A2 (pt)	2015-07-21	Método para preparar um composto e composto
ZA201001480B (en)	2011-05-25	Method for producing flu virus
BRPI0908192A2 (pt)	2015-08-25	Dispositivo funcional, e, método para produzir um dispositivo funcional
BRPI0719843A2 (pt)	2014-04-29	Método para a produção de bisbenzoxazóis
BRPI0812999A2 (pt)	2014-12-23	Método para preparar um composto
BRPI0812422A2 (pt)	2014-12-02	Processo de preparação de um aldeído hidroxiaromático
BRPI0807870A2 (pt)	2014-06-17	Método para a produção de um revestimento
BRPI0817978A2 (pt)	2015-04-07	Métodos para preparar um catalisador de polimerização
BRPI0816911A2 (pt)	2015-03-17	Processo para preparação de 4-aminobut-2-enolidas
BRPI0810067A2 (pt)	2014-10-21	Processo para a preparação de capecitabina
BRPI0922490A2 (pt)	2015-08-04	Método para produção de beta-santaleno
BRPI0816589A2 (pt)	2015-03-03	Método para formar um artigo e artigo respirável
BR112012009974A2 (pt)	2015-09-29	método para produzir grândulos que compreendem um perticida
BRPI0914674A2 (pt)	2015-10-20	processo para preparação de um pó
BRPI0815784A2 (pt)	2015-02-24	Processo para a preparação de 1,2-propanodiol
BRPI1012025A2 (pt)	2017-06-27	componente estrutural e método para produção de um componente estrutural.
BRPI0813858A2 (pt)	2015-01-06	Método para produzir peptídeo
BR112012001462A2 (pt)	2016-03-15	processo para preparar metil mercaptano.
BRPI0921882A2 (pt)	2015-12-29	processo para fabricar um composto.
BRPI0815971A2 (pt)	2015-02-18	Processo para a preparação de 1,2-propanodiol
BRPI1006763A2 (pt)	2016-10-25	material impresso, conjunto de material impresso e método para produzir um conjunto de material impresso
BRPI0818674A2 (pt)	2014-10-14	Método para produção de anticorpos